Understanding Clinical Research
to view meeting: https://youtu.be/n1eu9fZy3zE
June 9, 2026 - York East Rotary Club member Lisa Striffler recently provided an informative and fascinating presentation about the world of clinical research and the important role her company plays in helping bring new medications to market. Striffler, who has a background in nursing and earned her MBA, serves in a senior leadership role overseeing teams located across the globe. She explained that her company is a contract clinical research organization (CRO) that is hired by major pharmaceutical companies, including Pfizer, to manage and conduct the extensive clinical trials required before new drugs can receive approval from the U.S. Food and Drug Administration (FDA).
During her presentation, Striffler walked club members through the four phases of clinical research that every new drug must successfully complete before becoming available to the public. Phase I trials involve a small group of participants and focus primarily on determining the safety of a new drug and identifying potential side effects. Phase II studies expand testing to a larger group of patients to evaluate the drug's effectiveness while continuing to monitor safety. Phase III trials involve hundreds or even thousands of participants and compare the new treatment against existing therapies or placebos. The results from these studies provide the critical data needed for FDA review and approval. Phase IV research occurs after a drug has been approved and marketed, allowing researchers to continue monitoring long-term safety and effectiveness in a larger population.
Throughout every phase, Striffler emphasized that patient safety is the highest priority. Strict protocols, oversight committees, regulatory requirements, and continuous monitoring are all designed to protect participants and ensure the integrity of the research process. Her presentation provided valuable insight into the years of research, testing, and regulatory review that occur behind the scenes before a new treatment reaches a doctor's office or pharmacy. Members gained a greater appreciation for the scientific rigor and commitment to patient safety that are essential to advancing modern medicine.